CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- Open-market buys, last 90 days
- $226,500
- in 1 filing
- Open-market sales, last 90 days
- $4,661,919
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,435,419. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-15 | Kling Douglas F Chief Operating Officer | Sale 10b5-1 | −910 | 44,000 | ||
| 2025-04-15 | Kling Douglas F Chief Operating Officer | Option exercise · Option (right to buy) 10b5-1 | −100,000 | 550,930 | ||
| 2025-04-15 | Gulfo Adele M. Director | Grant or award | +10,860 | 10,860 | ||
| 2025-04-15 | Gulfo Adele M. Director | Grant or award · Option (right to buy) | +50,700 | 50,700 | ||
| 2025-04-14 | LANGE LOUIS G Director | Option exercise | +69 | 28,049 | ||
| 2025-04-14 | LANGE LOUIS G Director | Option exercise · Restricted Stock Unit | −69 | 137 | ||
| 2025-03-26 | Topper James N Director | Purchase | +1,135 | $22.49 | $26K | 3,013,569 |
| 2025-03-26 | Kooij Louise Frederika Chief Accounting Officer | Option exercise | +8,269 | 23,269 | ||
| 2025-03-26 | Kooij Louise Frederika Chief Accounting Officer | Grant or award · Restricted Stock Unit | +8,269 | 8,269 | ||
| 2025-03-26 | Kooij Louise Frederika Chief Accounting Officer | Option exercise · Restricted Stock Unit | −8,269 | 0 | ||
| 2025-03-26 | LANGE LOUIS G Director | Option exercise | +3,102 | 10,062 | ||
| 2025-03-26 | LANGE LOUIS G Director | Grant or award · Restricted Stock Unit | +3,308 | 3,308 | ||
| 2025-03-26 | LANGE LOUIS G Director | Option exercise · Restricted Stock Unit | −3,102 | 206 | ||
| 2025-03-26 | Kastelein Johannes Jacob Pieter Chief Scientific Officer | Grant or award | +19,302 | 169,302 | ||
| 2025-03-26 | Kastelein Johannes Jacob Pieter Chief Scientific Officer | Option exercise | +45,481 | 79,481 | ||
| 2025-03-26 | Kastelein Johannes Jacob Pieter Chief Scientific Officer | Grant or award · Restricted Stock Unit | +45,481 | 45,481 | ||
| 2025-03-26 | Kastelein Johannes Jacob Pieter Chief Scientific Officer | Option exercise · Restricted Stock Unit | −45,481 | 0 | ||
| 2025-03-26 | Kling Douglas F Chief Operating Officer | Option exercise | +16,539 | 60,539 | ||
| 2025-03-26 | Kling Douglas F Chief Operating Officer | Sale | −16,539 | 44,000 | ||
| 2025-03-26 | Kling Douglas F Chief Operating Officer | Grant or award · Restricted Stock Unit | +16,539 | 16,539 |
Page 9 of 15 · 300 trades